Nigel Brown
About
Detail
Founder Shareholder
Princeton, New Jersey, United States
Résumé
Jobs
verified_user
0% verified
Board MemberAlphalyseJun 2025 - Current (1 year 5 months)- InvestorAlethiosSep 2024 - Current (2 years 2 months)
- Investor and AdvisorAlethiosSep 2024 - Current (2 years 2 months)
- Board MemberUniversal Display CorporationMar 2024 - Current (2 years 8 months)Universal Display Corporation (NASDAQ: OLED) is lighting up the organic light emitting diode (OLED) revolution with its proprietary OLED technologies and proprietary phosphorescent materials. The Company is a world-class IP innovator, technology developer, patent licensor and materials supplier for the rapidly growing OLED markets. We are a leader in developing and delivering state-of-the-art, OLED technologies, materials and services to the display and lighting industries.
- Advisor - Rothschild & Co., Five Arrows Managers LLPRothschild CoJan 2024 - Current (2 years 10 months)
- VBoard MemberVorpal Technologies KKMar 2022 - Sep 2024 (2 years 7 months)
- Board MemberInotivNov 2021 - Current (5 years)At Inotiv (NASDAQ: NOTV), our focus is clinical decision support for development of new medicines: We deliver a comprehensive and integrated range of preclinical safety assessment services, analysis, bioanalysis, and DMPK and consulting solutions essential to drug development success.
- Board MemberMolecular DesignsOct 2021 - Current (5 years 1 month)Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics. Our mission is to simplify the delivery of molecular technologies. We do this by developing, producing, and supplying multiplex assays for research use. We believe individualized molecular data is the foundation for understanding and diagnosing many diseases.
- Board MemberStreamline ScientificOct 2021 - Current (5 years 1 month)Molecular insights are often the deciding factor for patient management. Our solutions empower researchers and physicians with the best data, faster and more efficiently. Whether you need to equip and optimize an existing lab or establish a new lab, Streamline Scientific equips healthcare providers and researchers with solutions that lower cost, yield faster, more accurate insights—driving better-informed research and treatment decisions.
- Senior AdvisorArsenal Capital PartnersOct 2021 - Dec 2023 (2 years 3 months)
- Board MemberMCRA an IQVIA businessMay 2021 - Sep 2024 (3 years 5 months)
- TPartner, Private EquityTrevi Health CapitalMar 2017 - Dec 2021 (4 years 10 months)
- CBoard MemberCytoVas LLCJul 2016 - Dec 2018 (2 years 6 months)
- LBoard MemberLifeBlood CorporationJun 2016 - Dec 2024 (8 years 7 months)LifeBlood is a privately held company dedicated to the introduction of a revolutionary and proprietary diagnostic test for the early detection of multiple sclerosis.
- Board MemberMedAvanteProPhaseJun 2016 - Jul 2017 (1 year 2 months)
- Fund AdvisorHealth Catalyst Capital HCCMay 2016 - Feb 2019 (2 years 10 months)
- PChief Executive OfficerPrinceton Healthcare Advisory LLCSep 2015 - Current (11 years 2 months)Founder of Princeton Healthcare Advisory LLC, a specialty advisory firm supporting growth-focused private equity, venture capital and strategic investors in the healthcare and life sciences sectors.
- VStrategic AdvisorVium IncSep 2015 - Oct 2018 (3 years 2 months)
- Corporate Vice President; Member of the Executive Committee; Head of Corp. Development & StrategyCovanceJun 2006 - Aug 2015 (9 years 3 months)
- Founder ShareholderMilestone Pharmaceuticals IncJan 2005 - Current (21 years 10 months)Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is a cardiovascular drug development company developing novel small molecule therapeutics based on clinically validated mechanisms. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as supraventricular tachycardia.
- Chairman of the Board, Board MemberBioAxone BioSciences IncJan 2001 - Aug 2019 (18 years 8 months)
- Editorial Advisory Board MemberDrug Discovery WorldJan 2000 - Dec 2020 (21 years)
- Senior Vice President; Member of the Executive Committee; GM, Preclinical Dev, CMC & RegulatoryMDS Pharma ServicesJan 2000 - Dec 2006 (7 years)
- PSenior Vice President & General Manager, Drug Discovery & Preclinical Development ServicesPhoenix International Life SciencesJan 1997 - May 2000 (3 years 5 months)
- AScientific Advisory Board MemberAlgene BiotechnologiesJan 1997 - Dec 1998 (2 years)
- Drug Metabolism & PharmacokineticsGSKJan 1993 - Dec 1997 (5 years)
- Drug Metabolism & PharmacokineticsPfizerJan 1991 - Dec 1993 (3 years)
Education
verified_user
0% verified
- Nestlé Post-Doctoral Fellowship, ToxicologyMassachusetts Institute of TechnologyJan 1990 - Dec 1991 (2 years)Research was conducted in the laboratory of Professor Steven Tannenbaum.
- Doctor of Philosophy - D.Phil, Physiological Sciences (Metabolism and Pharmacology)University of OxfordJan 1986 - Dec 1989 (4 years)Research conducted in the laboratory established by Professor Sir William Paton, FRS, with Professor David Harvey; moral tutor Professor Sir Philip Randle, FRS.
- B.A.(Hons, Chemistry with Chemical PharmacologyUniversity of OxfordJan 1982 - Dec 1986 (5 years)Principal tutors, Professor Keith McLauchlan, FRS, and Professor David Harvey.
- M.B.A, Business AdministrationThe Open UniversityReceived with Distinction in Business Strategy and International Enterprise
Projects (professional or personal)
verified_user
0% verified